Venbio Select Advisor LLC
Nombre legal: AVORO CAPITAL ADVISORS LLC
Detalles de contacto completos
Venbio Select Advisor LLC
110 GREENE STREET, SUITE 800, NEW YORK, NY
212-937-4970
646-757-2710
Otra información
AVORO CAPITAL ADVISORS LLC, antes conocida como Venbio Select Advisor LLC, es una empresa registrada como una Compañía de Responsabilidad Limitada de DE. Actualmente, la firma emplea a 9 personas, incluyendo 5 en roles de asesoramiento. Desafortunadamente, no sabemos cuántos clientes atienden. La SEC ha aprobado el estado de la empresa con una fecha de registro del 30 de marzo de 2012.
VenbioSelect.com is for sale | HugeDomains
Premium domains add authority to your site. Transparent pricing. 1 year WHOIS privacy included. 30-day money back guarantee.
Avoro Capital Advisors
Avoro Capital Advisors is a global firm focused on funding & investments in biotechnology, life sciences, and specialty therapeutics. Contact us today!
Propietarios directos
-
AVORO CAPITAL L.P.
DIRECT OWNER posee 75% o más
-
BEHZAD AGHAZADEH
MANAGING DIRECTOR posee menos de 5%
-
SCOTT ANDREW EPSTEIN
CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER posee menos de 5%
Propietarios indirectos
-
AVORO CAPITAL GP LLC
GENERAL PARTNER
-
BEHZAD AGHAZADEH
LIMITED PARTNER posee más del 50% pero menos del 75%
-
BEHZAD AGHAZADEH
MEMBER posee más del 50% pero menos del 75%
-
GARHENG ALBERT KONG
MEMBER posee más del 50% pero menos del 75%
Corredores principales
-
J.P. MORGAN SECURITIES LLC
Estados Unidos -
MORGAN STANLEY & CO. LLC
Estados Unidos
Empresas ubicadas cerca
- Twentyfour Asset Management US LP
- UBS Asset Management Americas Inc
- Mortgage Industry Advisory Corporation
- Cantillon Capital Management LLC
- Elliott Management Corporation
- Square MILE Capital Management LLC
- Sontag Advisory LLC
- Aretex Capital Management LP
- East Rock Capital LLC
- Clearbrook Investment Consulting LLC
Top Holdings
- MIRATI THERAPEUTICS INC $397,838k
- IMMUNOMEDICS INC $291,270k
- Iovance Biotherapeutics Inc $263,653k
- ASCENDIS PHARMA A S $226,846k
- BIOMARIN PHARMACEUTICAL INC $181,150k
- B. Riley Wealth Management, Inc. $145,425k
- AMICUS THERAPEUTICS INC $124,800k
- Argenx SE Sponsored ADR $118,927k
- ZOGENIX INC $96,755k
- HORIZON THERAPEUTICS PLC $96,240k